New computational approach identifies not so novel drugs to tackle ovarian cancer
The potential role of in silico approaches to identify novel bioactive molecules from natural resources
Lead to Hit, rather than Hit to Lead: why medicinal chemists at GlaxoSmithKline are working backwards
A novel 3D visualization tool: a promising workflow for mapping the lung’s chemical and microbial make-up?
Development of pyridine dicoumarols as potent anti HIV-1 leads, targeting HIV-1 associated topoisomeraseIIβ kinase
Computational chemistry reveals unexpected relationships between unrelated pharmaceutical target proteins